ELMD - Electromed, Inc. Trailing Twelve Months Revenue Growth

Electromed, Inc. (ELMD) is scaling SmartVest for COPD therapy, improving home-based lung treatment. Year-over-year (TTM) sales growth illustrates the asset's current momentum, where the 14.30 mark indicates the level of revenue development. The expansion of the sales agent workforce in the US is driving distribution. Effective management via direct marketing ensures high operating margins and a steady cash flow.
SmartVest (ELMD) - metric breakdowns and financial figures

Diversifying distribution channels for respiratory cleaning systems between the hospital and home segments provides Electromed, Inc. (ELMD) with a steady revenue stream. Analyzing this chart of year-over-year revenue growth over the last 12 months, investors assess the daily price action of business expansion relative to inflationary costs, noting that without a synchronous increase in net profit, even aggressive sales expansion does not guarantee a strengthening of quotes.